OUR CAPABILITIES
Phase I-Enabling Manufacturing
The NBF has a proven track record of working with our collaborators to develop programs through to Phase I clinical end points.
Process Scale-Up to 50 L
The NBF has established equipment platforms and process models to enable efficient tech transfer and scale-up from shake flask up to 50 L bioreactor scale, offering affordable production services whatever your application or material volume and quality requirements.
QC Release Testing and Stability Monitoring
We take a risk-based approach when establishing assays and specifications for each product destined for early phase clinical trial. The NBF can support your release and stability testing programs utilising qualified assays to ensure product quality, efficacy and safety.
Quality Management System
The NBF operates under a phase-appropriate Quality Management System certified to ISO 9001. We are committed to the development and manufacture of high-quality recombinant proteins and to a continuous improvement program which incorporates new technologies and practices in keeping with global best practice.